Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders https://www.medrxiv.org/content/10.1101/2023.08.15.23293564
Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders https://www.medrxiv.org/content/10.1101/2023.08.15.23293564